<DOC>
	<DOCNO>NCT00597675</DOCNO>
	<brief_summary>The purpose study determine mucosal peanut immunotherapy make subject peanut allergy less allergic induce change immune system .</brief_summary>
	<brief_title>Mucosal Immunotherapy Peanut Allergy</brief_title>
	<detailed_description>Peanut allergy know cause severe anaphylactic reaction . Compared food allergy tend persistent also prevalence seem rise . Currently prove treatment strict avoidance . We attempt decrease risk anaphylaxis accidental ingestion desensitize subject peanut use peanut mucosal immunotherapy ( MIT ) . We also study effect peanut MIT peanut specific immune response determine tolerance peanut protein develop . Children age one six peanut allergy randomize peanut MIT placebo . Subjects undergo modify rush immunotherapy first day increase dos least every two week maintenance dose 4 gram ( equivalent 13 peanut ) . Doses take daily home except dose increase do research unit . Outcome variables interest include response double-blind placebo control food challenge , skin prick testing , peanut specific IgE , adverse event . These result compare start end peanut MIT use appropriate statistical analysis .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Peanut Hypersensitivity</mesh_term>
	<mesh_term>Food Hypersensitivity</mesh_term>
	<criteria>Subject 1 6 year age Diagnosed peanut allergy immunoglobin E peanut ( IgE peanut ) great equal 15 within past 6 month eat peanut diet result clinical reaction prior diagnosis Diagnosed peanut allergy immunoglobin E peanut ( IgE peanut ) great equal 7 within past 6 month clinical reaction peanut ingestion within past 6 month Subjects history severe , anaphylaxis peanut Medical history would prevent double blind placebo control oral food challenge ( DBPCFC/OFC ) peanut</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>7 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Peanut allergy</keyword>
</DOC>